FIELD: medicine, gynecology.
SUBSTANCE: intravaginally one should introduce proteolytically immobilized enzyme - imosimase at the dosage of 5 ml (300PU) and basic combined antimycotic preparation on the 1st, 5th and 10th d of therapy. The present innovation enables to decrease the number of complications during pregnancy, in the course of delivery, during puerperal and early neonatal periods due to valuable vaginal sanitation.
EFFECT: higher efficiency of therapy.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CHRONIC RECURRENT VULVOVAGINITIS | 2009 |
|
RU2423978C1 |
METHOD OF PREVENTION AND TREATMENT OF VULVOVAGINITIS AND VAGINITIS | 2013 |
|
RU2566733C2 |
METHOD FOR TREATING VAGINAL CANDIDIASIS | 2001 |
|
RU2197255C1 |
METHOD FOR LOCAL TREATMENT OF BACTERIAL VAGINOSIS | 2003 |
|
RU2236851C1 |
METHOD FOR TREATMENT OF VAGINAL CANDIDOSIS | 2004 |
|
RU2254857C1 |
METHOD FOR TREATMENT OF RECURRENT VULVOVAGINAL CANDIDIASIS | 2016 |
|
RU2642666C1 |
METHOD OF TREATING VAGINAL DISBIOSES AND VAGINITES IN FEMALES SUFFERING CHRONIC SALPINGO-OOPHORITIS | 2010 |
|
RU2445135C1 |
PHARMACOLOGICAL COMPOSITION FOR TREATMENT OF CANDIDOSE VULVAVAGINATES | 2007 |
|
RU2354385C2 |
METHOD FOR TREATING RECURRENT FORMS OF FEMALE UROGENITAL CANDIDIASIS | 1999 |
|
RU2147434C1 |
METHOD OF TREATING UROGENITAL CANDIDIASIS USING ULTRASONIC CAVITATION AND PHOTOCHROMOTHERAPY | 2019 |
|
RU2704470C1 |
Authors
Dates
2005-10-27—Published
2004-04-12—Filed